ICD-10 Coding for Hypercoagulability(D68.5, D68.51, D68.51A)
Learn about ICD-10 coding for hypercoagulability, including primary and secondary codes, documentation requirements, and common pitfalls.
Complete code families applicable to Hypercoagulability
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D68.51 | Activated protein C resistance | Use when genetic testing confirms Factor V Leiden mutation. |
|
| D68.69 | Other thrombophilia | Use when hypercoagulability is secondary to another condition like malignancy. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutHypercoagulability
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Hypercoagulability.
Documenting 'clotting disorder' without specifying type
Impact
Clinical: Leads to vague diagnosis and treatment plans., Regulatory: Non-compliance with documentation standards., Financial: Potential for claim denials.
Mitigation
Specify if the disorder is inherited or acquired., Link to specific conditions when applicable.
Coding hypercoagulability based solely on abnormal lab results
Impact
Reimbursement: Incorrect coding may lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate patient records.
Mitigation
Ensure clinical documentation supports hypercoagulability diagnosis.
Incorrect use of D68.69
Impact
Using D68.69 without documented secondary cause.
Mitigation
Ensure documentation clearly links hypercoagulability to a secondary condition.